Company Snapshot

Investment Thesis

ResMed develops CPAP devices, masks, and digital solutions treating sleep apnea and chronic respiratory conditions. Home sleep testing, connected devices, and SaaS offerings drive recurring revenue.

  • Connected Devices: Cloud-enabled CPAP units power remote monitoring and adherence.
  • Mask Refresh Cycle: Consumable mask replacements create high-margin recurring sales.
  • Software Ecosystem: MatrixCare/Brightree platforms extend into home health and hospice.

Strategic Mix

Devices CPAP machines, ventilators, and life support systems
Masks & Accessories Consumables for sleep and respiratory therapy
SaaS Brightree, MatrixCare, and other out-of-hospital software
International Significant revenue from EMEA/APAC markets

Mix aligns with ResMed's devices, masks, and SaaS disclosures.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Untreated Population

Underdiagnosed sleep apnea worldwide expands TAM.

Reimbursement Tailwinds

Remote monitoring improves compliance and payer outcomes.

Digital Health

Integrated software helps providers manage home-based care.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...